Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2020 Jun 1;130(6):3329. doi: 10.1172/JCI138278

RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass

Nicolas Bonnet, Lucie Bourgoin, Emmanuel Biver, Eleni Douni, Serge Ferrari
PMCID: PMC7260021  PMID: 32478683

Original citation: J Clin Invest. 2019;129(8):3214–3223. https://doi.org/10.1172/JCI125915

Citation for this corrigendum: J Clin Invest. 2020;130(6):3329. https://doi.org/10.1172/JCI138278

Following the publication of this article, errors were noted in Figure 1, B and C. The authors were able to provide the original data, and a corrected version of Figure 1 appears below.

graphic file with name jci-130-138278-g461.jpg

The online version of the article has been updated with the corrected information.

The authors regret the errors.

Version 1. 06/01/2020

Print issue publication

Footnotes


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES